KB Securities: "Classys weak in Latin American unit and domestic sales… expects growth recovery next year"
Predicted impact: Low
Broker note on weak Latin American and domestic sales; company-level impact appears modest.
Classys클래시스
214150 · KOSDAQ · ₩214150 · 클래시스
₩26,800▼ ₩200 (0.74%)End-of-day · Oct 29, 2026 · End-of-day prices.
Price · 1Y −45.03%
- Market cap
- ₩1.7T
- Enterprise value
- ₩1.8T
- P/E
- 12.7×
- P/B
- 3.2×
- Dividend yield
- 3.7%
- ROE
- 25.0%
- Net margin
- 37.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−65.5% from the high
₩25,850Today: ₩25,850 – ₩27,300₩77,600
Returns
- 1W−5.6%
- 1M−12.8%
- 3M−28.6%
- 6M−51.8%
- YTD−50.8%
- 1Y−45.0%
- Volume today
- 268,388
- 1.4× the 20-day average
- Traded today
- ₩7.1B
- Listed shares
- 65,235,659
- EPS (12 months)
- ₩2,110
- Earnings yield 7.9%
AI research · InitiationClassys: Shares down 39.4% over a year while profits kept growing and multiples compressedThe filed numbers show a highly profitable business with a record of growth, and valuation multiples that have compressed to roughly half of year-end 2025 levels as the share price fell.Read the full report →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 47 of 100 (50 is a normal day for this stock).
- SentimentNegativeNews: Weak regional sales are offset by a forecast of recovery next year. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-12.8% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
- StreetSteady1 brokers, average target 68% from the price; last 30 days: 0 raised, 0 cut.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Oct 29: sell ₩517M at the close (9.9% of 20-day average trading value)
On its 15 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 32.2% of trading value and pointed the same way 11 of 15 times.
- 2× KODEX KOSDAQ150 Leverage −₩360M
- -1× KODEX KOSDAQ150 Futures Inverse −₩89M
- 2× TIGER KOSDAQ150 Leverage −₩44M
- 2× RISE KOSDAQ150 Futures Leverage −₩17M
- -1× TIGER KOSDAQ150 Futures Inverse −₩2.9M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
ETFs holding this
All ETFs →Held by 11 funds.
- KODEX KOSDAQ1500.7%
- KODEX KOSDAQ150 Leverage2×0.7%
- TIGER KOSDAQ1500.7%
- RISE KOSDAQ1500.7%
- TIGER KOSDAQ150 Leverage2×0.7%
- ACE KOSDAQ 1500.7%
- KIWOOM KOSDAQ1500.7%
- SOL KOSDAQ1500.7%
Estimated from the funds' index or underlying stock.
Futures and options
All stock futures →Futures (2026-11): 26,750
Basis −0.19% · implied rate −4.9%
Open interest 12,372 contracts
Futures and options can lose more than you put in. Figures describe the market; they are not predictions or recommendations. Paper trading only.
Classys stock overview
Classys (클래시스, KRX: 214150) is listed on KOSDAQ, in the Medical & precision devices sector. Classys is a Korean company that designs, manufactures and sells medical devices for aesthetic purposes. Its shares closed at ₩26,800 on Oct 29, 2026, down 0.74% on the day, giving it a market value of ₩1.7T.
Key facts
- Market cap
- ₩1.7T
- Sector
- Medical & precision devices
- Latest price change
- −0.74%
- As of
- Oct 29, 2026
- Main business
- Classys is a Korean company that designs, manufactures and sells medical devices for aesthetic purposes.
Quick answers about Classys
- What does Classys do?
- Classys is a Korean company that designs, manufactures and sells medical devices for aesthetic purposes. Its main products are energy-based systems such as HIFU (Ultraformer), monopolar RF (Volnewmer/Everesse), microneedle RF (Quadessy) and laser devices (reepot), along with consumables needed to operate them. Its customers include distributors in about 80 countries, domestic and overseas clinics, and individual consumers, and it also sells home-use beauty devices and cosmetics.
- What is the market cap of Classys?
- The market capitalisation of Classys was ₩1.7T at the close on Oct 29, 2026.
- What is the analyst target price for Classys?
- The average target price of 1 broker covering Classys is ₩45,000 (range ₩45,000 to ₩45,000), 67.9% above versus the latest price, based on each broker's latest public report within six months.
- Who are the largest shareholders of Classys?
- According to the latest official filings, the largest reported holders are BCPECenturInvestments,LP (45.91%, as of Feb 27, 2026); CapitalResearchandManagementCompany (5.10%, as of Sep 3, 2026); National Pension Service (2.06%, as of Dec 31, 2025).
- When is the next earnings report from Classys?
- Korean companies rarely announce results dates in advance. Based on when Classys filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Classys?
- Yes. The National Pension Service held 2.06% of Classys shares as of Dec 31, 2025.
Company profile
Classys is a Korean company that designs, manufactures and sells medical devices for aesthetic purposes. Its main products are energy-based systems such as HIFU (Ultraformer), monopolar RF (Volnewmer/Everesse), microneedle RF (Quadessy) and laser devices (reepot), along with consumables needed to operate them. Its customers include distributors in about 80 countries, domestic and overseas clinics, and individual consumers, and it also sells home-use beauty devices and cosmetics. Most of its sales are overseas, sold mainly through distributors and, in Japan and Brazil, through its own subsidiaries.
Written by AI from the company's latest annual report.
- Korean name
- 클래시스
- CEO
- Jun-oh Yoon
- Founded
- Jan 2015
- Listed
- Apr 2015
- Listed shares
- 65,235,659
- Fiscal year ends
- Month 12
- Website
- classys.co.kr
Similar companies
- TSE131290 · ₩2.9T₩260,500−5.27%
- Kctech281820 · ₩1.9T₩97,500+2.09%
- Park Systems140860 · ₩1.6T₩228,500−0.44%
- DI003160 · ₩1.2T₩43,500+0.46%
- Curiox Biosystems445680 · ₩1T₩60,600−2.88%
- LivsMed491000 · ₩1T₩40,450−7.33%
- Seers458870 · ₩907B₩23,650−3.86%
- SD Biosensor137310 · ₩758B₩6,280+0.32%
Recent news
Classys hires Bain & Company veteran Bae Jeong-hee as vice president
Predicted impact: Low· Actual: +14.1% vs sector, volume 1.6× normal (5 trading days)
Senior hire as vice president; routine personnel change.
Cosmax-linked Classys: quarterly sales ₩100B, donation ₩500K
Predicted impact: Low· Actual: +4.5% vs sector, volume 1.7× normal (5 trading days)
Quarterly sales around 100 bln won and a small donation; routine, no major surprise indicated.
Recent filings
See all- Investor relations (IR) eventOct 6, 2026
- Investor relations (IR) eventSep 28, 2026
- Investor relations (IR) eventSep 15, 2026
- Investor relations (IR) eventSep 9, 2026
- 5%+ holding reportSep 3, 2026
Titles in Korean until English translations are added.
Also known as: Classys / 클래시스 / 214150 / KRX:214150
Source: KRX statistical information